Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbor & Canton is a specialized investment management firm dedicated to the global healthcare and life sciences industries. The firm was founded by Dr. Yi Shi, a prominent figure in healthcare venture capital, and operates with a focus on identifying transformative medical innovations. Harbor & Canton invests across various stages of company growth, including early-stage venture capital and public equity markets. Their investment strategy is rooted in deep fundamental research and a thorough understanding of clinical development and regulatory pathways. By providing both capital and strategic expertise, the firm supports companies developing breakthrough therapies in areas such as oncology, immunology, and rare diseases. Harbor & Canton maintains a global presence with offices in key financial and biotech hubs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbor & Canton Capital.